Generation Bio Co (GBIO)
3.64
-0.13
(-3.45%)
USD |
NASDAQ |
May 17, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Generation Bio Total Liabilities (Quarterly): 153.89M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 153.89M |
| December 31, 2023 | 171.63M |
| September 30, 2023 | 149.58M |
| June 30, 2023 | 150.60M |
| March 31, 2023 | 152.28M |
| December 31, 2022 | 93.77M |
| September 30, 2022 | 94.05M |
| June 30, 2022 | 94.12M |
| March 31, 2022 | 91.11M |
| Date | Value |
|---|---|
| December 31, 2021 | 95.02M |
| September 30, 2021 | 56.82M |
| June 30, 2021 | 57.39M |
| March 31, 2021 | 55.34M |
| December 31, 2020 | 26.14M |
| September 30, 2020 | 24.38M |
| June 30, 2020 | 27.05M |
| March 31, 2020 | 22.86M |
| December 31, 2019 | 140.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.86M
Minimum
Mar 2020
171.63M
Maximum
Dec 2023
92.04M
Average
93.91M
Median
Total Liabilities (Quarterly) Benchmarks
| Quantum-Si Inc | 21.81M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.88M |
| Shareholders Equity (Quarterly) | 131.99M |
| Current Ratio | 8.013 |